The Valley Desk

EditorialJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished

Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In Favor

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Editorial
Venue
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Antibodies, Monoclonal, Humanized; B7-H1 Antigen
PubMed ID
36842810
Added to directory
Source checked

Report a correction or request removal